22nd Century (XXII)

Search documents
VLN Commercial Launches Confirm Viability of the FDA's Proposed Reduced Nicotine Mandate
GlobeNewswire News Room· 2025-07-16 21:18
Core Insights - 22nd Century Group is expanding the availability of its VLN® reduced nicotine content products through partnerships with multiple tobacco brands, aiming to reduce smoking rates and related health harms [1][2][3] - The FDA's proposed Tobacco Product Standard for nicotine yield, which sets a maximum nicotine content of 0.7 mg per gram of tobacco, is driving interest in VLN products, which average 0.5 mg per gram [3][4][5] - The implementation of the FDA's proposal could prevent approximately 48 million youth and young adults from starting to smoke by the year 2100 [4][6] Company Overview - 22nd Century Group is recognized as a pioneering company in nicotine harm reduction, providing smokers with options to control their nicotine consumption [7][8] - The VLN® cigarette is designed to offer a familiar alternative for traditional smokers, containing 95% less nicotine than conventional cigarettes [8][9] - The company holds a comprehensive patent portfolio that ensures it has the only low nicotine combustible cigarette in the U.S. and critical international markets [9]
22nd Century Provides Corporate Update On Its VLN® MRTP Renewal Process – The First and Only Combustible Tobacco Product Authorized by the FDA Specifically to Help Smokers Smoke Less
Globenewswire· 2025-07-10 12:00
Core Insights - 22nd Century Group, Inc. is leading the fight against smoking-related health harms through its VLN reduced nicotine content products, which are the first and only combustible cigarettes authorized by the FDA to reduce health risks associated with smoking [1][2][4] Product Overview - VLN cigarettes contain 95% less nicotine than conventional cigarettes, supported by decades of independent clinical research demonstrating their effectiveness in reducing nicotine consumption, smoking rates, and increasing quit attempts [2][4] - The VLN product line is designed to provide smokers with non-addictive alternatives, allowing them to control their nicotine intake and potentially reduce tobacco use [2][4] Regulatory Status - The VLN product was originally authorized in December 2021, with a renewal process due in December 2026, and the company expects full FDA support for this renewal based on its compliance with the FDA's low nicotine mandate issued in January 2025 [2][4] Research and Development - The company is committed to ongoing R&D programs aimed at advancing reduced nicotine content in tobacco and introducing additional VLN-based products to offer more health-oriented alternatives to traditional tobacco products [2][4] Company Mission - 22nd Century Group aims to empower smokers to make informed choices regarding their nicotine consumption, promoting a healthier lifestyle by providing options that help avoid addictive levels of nicotine altogether [4][5]
22nd Century Announces Operation 100 – A 100mm VLN® Cigarette Designed to Reach Even More Adult Smokers Who Want to Reduce Their Nicotine Consumption
GlobeNewswire News Room· 2025-06-26 12:00
Core Insights - 22nd Century Group is advancing a 100mm VLN® reduced nicotine content cigarette, targeting an FDA submission by Q4 2025, expanding its product line aimed at nicotine harm reduction [1][4] - The new 100mm product is designed to appeal to approximately half of the U.S. smoking population who prefer this size, enhancing the reach of VLN® products [3][4] - The company emphasizes that its proprietary reduced nicotine content tobacco has been validated through independent clinical studies, demonstrating effectiveness in reducing smoking behaviors [3][6] Product Development - The 100mm VLN® cigarette will be available under both VLN® branding and partner brands like Smoker Friendly and Pinnacle, if authorized [2] - The VLN® cigarette contains 95% less nicotine than traditional cigarettes, which has been shown to help smokers reduce consumption and increase quit attempts [6][9] Market Position - 22nd Century Group is positioned as a pioneering company in nicotine harm reduction within the tobacco industry, focusing on providing smokers with choices to control their nicotine consumption [5][7] - The company operates a manufacturing facility in Mocksville, North Carolina, capable of producing over 45 million cartons of combustible tobacco products annually, with room for expansion [8]
22nd Century Announces Second Partner VLN Product Deal as Part of Major Pinnacle Brand Expansion Agreement with Top-5 C-Store Chain
Globenewswire· 2025-06-24 13:00
Core Insights - 22nd Century Group, Inc. is launching new Pinnacle VLN and moist snuff products in over 1,700 stores across 27 states, marking a significant expansion in its product offerings [1][2] - The new products include Pinnacle VLN Gold and Menthol VLN cigarettes, which are expected to begin sales in late summer and early fall of 2025 [2][4] - The company aims to leverage its established Pinnacle brand, which has a strong sales track record, to drive success in the new product categories [2][5] Product Launch Details - The launch includes four new Pinnacle SKUs, with two specifically in the low nicotine category [1] - The moist snuff products will feature straight and wintergreen flavors, expected to be available in the second half of 2025 [4] - The manufacturing of these products will utilize proprietary VLN tobacco strains and will be distributed through existing national-scale distribution agreements [5][6] Company Background - 22nd Century Group is recognized as a pioneering nicotine harm reduction company, focusing on enabling smokers to control their nicotine consumption [7] - The flagship VLN cigarette contains 95% less nicotine than traditional cigarettes, providing an alternative for smokers looking to reduce their nicotine intake [8][10] - The company operates a facility in Mocksville, North Carolina, with the capacity to produce over 45 million cartons of combustible tobacco products annually [9]
22nd Century Group (XXII) Conference Transcript
2025-05-21 17:00
Summary of 22nd Century Group (XXII) Conference Call - May 21, 2025 Company Overview - **Company Name**: 22nd Century Group Inc. - **Ticker Symbol**: XXII - **Headquarters**: Mocksville, North Carolina - **Industry**: Tobacco, specifically focused on nicotine harm reduction - **Key Brands**: VLN, Smoker Friendly, Pinnacle Core Points and Arguments - **Nicotine Harm Reduction**: The company is a pioneer in the nicotine harm reduction space, offering products with significantly lower nicotine content, specifically the VLN brand which contains 95% less nicotine than standard cigarettes [3][11][41] - **FDA Compliance**: 22nd Century Group's VLN products are the only FDA-authorized low nicotine combustible cigarettes, aligning with the FDA's low nicotine mandate issued in January 2025 [5][34] - **Market Strategy**: The company aims to create a new low nicotine category (VLNC) to differentiate its products from traditional cigarettes, similar to how light beers are marketed [4][7] - **Growth Initiatives**: Plans to expand the VLN product line with new SKUs and partner brands, enhancing market penetration through existing retail relationships [6][18][22] - **Retail Presence**: Currently, the company has products in 5,100 retail stores across 26 states, with plans to expand to all 50 states [21][23] Financial Performance - **Debt Reduction**: The company has reduced its debt from over $20 million to $3.9 million, aiming for a debt-free status in the future [31][36] - **Operational Efficiency**: Operating expenses have decreased to under $2 million, with a target to reach breakeven by Q4 2025 [31][37] Market Dynamics - **Consumer Trends**: There is a growing awareness and demand for nicotine harm reduction products, with billions being spent on awareness campaigns [10][12] - **Competitive Landscape**: Traditional tobacco companies continue to focus on high-nicotine products, which creates a market opportunity for 22nd Century Group to position itself as a healthier alternative [42][43] Product Development - **R&D Focus**: The company is working on expanding its product offerings, including non-combustible low nicotine products and new tobacco strains through partnerships with research institutions [29][30] - **New Product Launch**: Smoker Friendly has introduced a natural cigarette product, Smoker Friendly Black Label, which is positioned as a cost-effective alternative to premium brands [25][27] Consumer Targeting - **Ideal Customers**: The target market includes smokers looking to reduce their nicotine dependence, such as pregnant women or those in restrictive work environments [45][46] Additional Insights - **Marketing Strategy**: The company is revamping its branding to make it more appealing and accessible to consumers, aiming to capture attention in retail environments [9][16][20] - **Long-term Vision**: The company is focused on establishing itself as a leader in the low nicotine category, with a commitment to consumer choice and health [8][34][41] This summary encapsulates the key points discussed during the conference call, highlighting the company's strategic direction, market positioning, and financial health.
Emerging Growth Research Releases Q1 2025 Update Report on 22nd Century Group
Newsfile· 2025-05-21 13:00
Core Insights - Emerging Growth Research released a quarterly update report on 22nd Century Group, highlighting operational progress and a positive financial outlook for 2025 [1][4] Financial Performance - 22nd Century Group reported Q1 2025 revenue of $6.0 million, an 8% decrease year-over-year from $6.5 million in Q1 2024, but a significant 48% increase compared to $4.0 million in Q4 2024 [3][8] - Gross profit improved to $(0.6) million in Q1 2025 from $(1.3) million in Q4 2024 [8] - Operating loss narrowed to $(2.6) million from $(4.4) million in Q1 2024 [8] - EBITDA improved to $(2.5) million from $(4.2) million in Q1 2024 [8] Debt and Cash Position - The company's cash position strengthened following a Q2 2025 partial warrant inducement that generated $5.4 million in gross proceeds, with $1.0 million used to repay debt [5] - Total debt reduced to approximately $3 million as of May 7, 2025, resulting in a net cash positive position [5][8] - Management anticipates sufficient cash reserves to maintain operations through year-end 2025 [5] Product Development and Market Position - The VLN® cigarettes, which contain 95% less nicotine than conventional cigarettes, are gaining traction in the marketplace [6] - Management estimates that only 223,000 VLN® cartons are needed to reach profit breakeven, indicating significant growth potential [6] - The company plans to launch additional products, including VLN® SKUs within private label CMO customer brand families [7]
22nd Century to Present at the Emerging Growth Conference on May 21, 2025
Globenewswire· 2025-05-19 20:15
Core Insights - 22nd Century Group, Inc. is focused on nicotine harm reduction and offers smokers choices regarding their nicotine consumption [3][4] - The company will present a corporate update at the Emerging Growth Conference on May 21, 2025, led by CEO Larry Firestone [1][2] Company Overview - 22nd Century Group is a pioneering company in the tobacco industry, enabling smokers to control their nicotine intake [3] - The flagship product, VLN cigarettes, contains 95% less nicotine than traditional cigarettes and aims to reduce overall nicotine consumption [4][6] Product and Technology - VLN cigarettes are designed to provide an authentic smoking experience while allowing smokers to make informed choices about nicotine levels [4] - The company utilizes patented technologies to create reduced nicotine tobacco blends, ensuring high flavor and yield with significantly lower nicotine content [6] Manufacturing Capabilities - The company operates a 60,000 square foot facility in Mocksville, North Carolina, capable of producing over 45 million cartons of combusted tobacco products annually, with room for expansion [5] - The facility also provides turnkey contract manufacturing for other tobacco brands both domestically and internationally [5]
22nd Century (XXII) - 2025 Q1 - Earnings Call Transcript
2025-05-13 13:02
Financial Data and Key Metrics Changes - Net revenue for Q1 2025 was $6 million, a 50% increase sequentially from $4 million in Q4 2024 [28] - Gross margin showed a loss of $600,000, which is an improvement of 50% from the prior quarter [28] - Net loss from continuing operations improved to $3.3 million from $4.2 million in the preceding quarter [31] - Adjusted EBITDA loss improved to $2.3 million from $3.9 million in Q4 2024 [31] Business Line Data and Key Metrics Changes - Total cartons sold were 476,000, an increase of 41% compared to 338,000 in Q4 2024 [29] - The company is focusing on two main segments: reduced nicotine premium products and value-focused CMO brands [10][12] Market Data and Key Metrics Changes - The combustible cigarette market is valued at $85 billion, facing increasing price pressures and regulatory challenges [6] - The company aims to serve the Tier four market, which is approximately two-thirds the price of Tier one brands [10] Company Strategy and Development Direction - The company is transitioning into a growth model, focusing on expanding distribution and launching targeted marketing campaigns [12][20] - New product introductions include Smoker Friendly Black Label and VLN branded products, aimed at capturing market share in the natural cigarette and low nicotine segments [14][15] - The company is not waiting for FDA regulations to finalize its strategy and has developed technology for low nicotine tobacco products [22][23] Management's Comments on Operating Environment and Future Outlook - Management believes the current market dynamics present opportunities for high-quality branded products due to price pressures from big tobacco [21] - The company is on track to achieve breakeven EBITDA by Q4 2025, with expectations of revenue growth and margin improvement [25][35] Other Important Information - The company reduced its outstanding debt to $3.9 million, with debt-for-equity conversions of $3.1 million during the quarter [31] - A capital raise through warrant inducement raised approximately $5.4 million, providing cash runway for growth initiatives [32] Q&A Session Summary Question: Do you still foresee a breakeven of EBITDA for the fourth quarter of this year? - Yes, the company is on track to achieve breakeven in the latter half of the year [35] Question: Will CMO continue to grow from its first quarter level and will VLN kick in over the course of the year? - Yes, both Smoker Friendly and Pinnacle franchises are on a growth path, and state approvals for VLN will enhance distribution [36][37] Question: Does the increase in accounts receivable indicate a need for additional financial capital? - The company is comfortable with its cash runway after recent financing and the increase in receivables is due to new customer agreements [38][39] Question: What is the expected collection period for the accounts receivable balance? - The collection terms are typical for shipments, generally collected upon product delivery [40] Question: What has been the share issuance dilution from the warrants? - Current shares outstanding include approximately 7 million shares issued under the recent warrant inducement offering [42] Question: Are there any implications for twenty second Century Group from competitors' earnings results? - The company sees opportunities in the value segment due to price increases in the market and is anticipating the launch of partner VLNs [46][47] Question: Have we seen the worst of it in 2024, and are we now on a growth trajectory? - Yes, the company is now on a growth trajectory in terms of cartons, price, and revenue [48]
22nd Century (XXII) - 2025 Q1 - Earnings Call Transcript
2025-05-13 13:00
Financial Data and Key Metrics Changes - Net revenue for Q1 2025 was $6 million, a 50% increase sequentially from $4 million in Q4 2024 [28] - Gross margin loss improved by 50% to a loss of $600,000 from the previous quarter [28] - Net loss from continuing operations improved to $3.3 million from $4.2 million in the preceding quarter [31] - Adjusted EBITDA loss significantly improved to $2.3 million from $3.9 million in Q4 2024 [31] Business Line Data and Key Metrics Changes - Total cartons sold were 476,000, an increase of 41% compared to 338,000 in Q4 2024 [29] - The company is focusing on two main segments: reduced nicotine premium products and value-focused CMO brands [9][10] Market Data and Key Metrics Changes - The combustible cigarette market is valued at $85 billion, facing increasing price pressures and regulatory scrutiny [6] - The company aims to serve consumers transitioning from high nicotine products to lower nicotine options, capitalizing on market dynamics [21] Company Strategy and Development Direction - The company is transitioning into a growth phase, focusing on expanding distribution and launching targeted marketing campaigns [12][20] - New product introductions include Smoker Friendly Black Label and additional SKUs for existing brands, aimed at increasing market share [14][15] - The company is not waiting for FDA regulations to finalize its strategy and has developed technology for low nicotine products already approved by the FDA [22][23] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about achieving breakeven EBITDA by Q4 2025, supported by improved pricing structures and volume growth [34][36] - The company is focused on restoring fiscal responsibility and improving balance sheet ratios through debt reduction and working capital improvements [27] Other Important Information - The company has reduced its outstanding debt to $3.9 million and executed a capital raise of approximately $5.4 million [31][32] - A lawsuit against Dorchester Insurance Company for $9 million in business interruption insurance is ongoing, with a trial date set for November 2025 [32] Q&A Session Summary Question: Do you still foresee a breakeven of EBITDA for the fourth quarter of this year? - Management confirmed they are on track to achieve breakeven in the latter half of the year [34] Question: Will CMO continue to grow from its first quarter level and will VLN kick in over the course of the year? - Management indicated that both Smoker Friendly and Pinnacle franchises are on a growth path, with state approvals expected to drive distribution [36] Question: Does the increase in accounts receivable indicate a need for additional financial capital? - Management stated they are comfortable with their cash runway following recent financing and attributed the increase in receivables to new customer agreements [38][39] Question: What is the expected timeline for collecting the accounts receivable balance? - Management noted that collections occur upon product delivery, following typical shipment terms [40] Question: What has been the share issuance dilution from the warrants? - Current shares outstanding include approximately 7 million shares issued under the recent warrant inducement offering, with additional warrants expected to be exercised [42] Question: Are there any implications for twenty second Century Group from competitors' earnings results? - Management highlighted that trends in the market, particularly the migration from Tier one to Tier four brands, present opportunities for the company [46][48] Question: Have we seen the worst of it in 2024 past, and are we now on a growth trajectory? - Management confirmed that they are now on a growth trajectory in terms of cartons, price, and revenue [49]
22nd Century (XXII) - 2025 Q1 - Quarterly Report
2025-05-13 10:30
[Part I. Financial Information](index=3&type=section&id=PART%20I.%20FINANCIAL%20INFORMATION) [Item 1. Financial Statements](index=3&type=section&id=Item%201.%20Financial%20Statements) Q1 2025 financials show decreased cash, improved losses, and a going concern warning due to working capital deficit and low cash [Condensed Consolidated Balance Sheets](index=3&type=section&id=Condensed%20Consolidated%20Balance%20Sheets) As of March 31, 2025, cash significantly decreased to $1.1 million, total liabilities rose to $17.8 million due to current reclassification, and equity declined Condensed Consolidated Balance Sheet Highlights (in thousands) | Account | March 31, 2025 | December 31, 2024 | | :--- | :--- | :--- | | **Assets** | | | | Cash and cash equivalents | $1,133 | $4,422 | | Accounts receivable, net | $4,322 | $1,698 | | Total current assets | $11,095 | $11,522 | | Total assets | $21,458 | $21,673 | | **Liabilities & Equity** | | | | Total current liabilities | $16,396 | $9,962 | | Long-term debt | $0 | $5,165 | | Total liabilities | $17,833 | $17,661 | | Total shareholders' equity | $3,625 | $4,012 | [Condensed Consolidated Statements of Operations and Comprehensive Loss](index=4&type=section&id=Condensed%20Consolidated%20Statements%20of%20Operations%20and%20Comprehensive%20Loss) Q1 2025 saw net revenues decrease to $6.0 million, but gross, operating, and net losses significantly narrowed due to cost controls and lower cost of goods sold Q1 2025 vs Q1 2024 Performance (in thousands, except per-share data) | Metric | Q1 2025 | Q1 2024 | | :--- | :--- | :--- | | Revenues, net | $5,956 | $6,469 | | Gross (loss) profit | $(609) | $(1,129) | | Operating loss from continuing operations | $(2,570) | $(4,434) | | Net loss from continuing operations | $(3,274) | $(5,450) | | Net loss | $(4,328) | $(5,739) | | Basic and diluted loss per common share | $(2.50) | $(395.07) | [Condensed Consolidated Statements of Cash Flows](index=6&type=section&id=Condensed%20Consolidated%20Statements%20of%20Cash%20Flows) Q1 2025 net cash used in operating activities increased to $3.0 million, resulting in a $3.3 million net decrease in cash, ending at $1.1 million Cash Flow Summary (in thousands) | Activity | Three Months Ended March 31, 2025 | Three Months Ended March 31, 2024 | | :--- | :--- | :--- | | Net cash used in operating activities | $(2,976) | $(2,255) | | Net cash (used in) provided by investing activities | $(59) | $15 | | Net cash (used in) provided by financing activities | $(254) | $1,699 | | **Net decrease in cash and cash equivalents** | **$(3,289)** | **$(541)** | | Cash and cash equivalents - end of period | $1,133 | $1,517 | [Notes to Condensed Consolidated Financial Statements](index=7&type=section&id=Notes%20to%20Condensed%20Consolidated%20Financial%20Statements) Notes detail a 'going concern' warning, reverse stock splits, discontinued operations, complex debt, legal proceedings, and subsequent capital-raising events - The company's significant losses and negative cash flows raise **substantial doubt** about its ability to continue as a **going concern** for the next year, prompting management to explore expense reduction and capital raising strategies[21](index=21&type=chunk)[22](index=22&type=chunk)[23](index=23&type=chunk) - The company completed **two reverse stock splits** (1-for-16 and 1-for-135) in 2024 to regain **Nasdaq listing requirements** compliance, with all share data retroactively adjusted[26](index=26&type=chunk) - The Senior Secured Credit Facility has undergone **numerous amendments**, with **$4.6 million** outstanding as of March 31, 2025, and **$3.1 million** of debt converted into 518,600 shares in January 2025[57](index=57&type=chunk)[68](index=68&type=chunk)[78](index=78&type=chunk) - Subsequent to quarter-end, a warrant inducement offering in April 2025 raised approximately **$5.4 million** in gross proceeds, and the Needle Rock Farms property was sold for **$770 thousand** in May 2025[134](index=134&type=chunk)[136](index=136&type=chunk)[138](index=138&type=chunk) [Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations](index=37&type=section&id=Item%202.%20Management%27s%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Management discusses Q1 2025 revenue decline, improved losses due to cost controls, critical liquidity issues, and subsequent capital-raising efforts to address going concern doubts [Results of Operations](index=39&type=section&id=Results%20of%20Operations) Q1 2025 net revenues decreased by 7.9% to $6.0 million due to repriced cigar contracts, but improved gross and operating losses resulted from significant expense reductions Q1 2025 vs Q1 2024 Operating Results (in thousands) | Metric | Q1 2025 | Q1 2024 | Change (%) | | :--- | :--- | :--- | :--- | | Revenues, net | $5,956 | $6,469 | (7.9)% | | Gross (loss) profit | $(609) | $(1,129) | (46.1)% | | Sales, general and administrative | $1,799 | $2,906 | (38.1)% | | Research and development | $162 | $425 | (61.9)% | | Operating loss from continuing operations | $(2,570) | $(4,434) | (42.0)% | - Cigarette sales volume **increased** from new CMO contracts, while filtered cigar revenue **decreased** due to contract repricing, and VLN® cigarette net revenues were **negative** from return accruals[147](index=147&type=chunk) - SG&A expenses **decreased by $1.1 million** due to lower headcount, reduced consulting and legal costs, and lower insurance, while R&D expenses **decreased by $263 thousand** from lower headcount and reduced tobacco agreements[146](index=146&type=chunk)[149](index=149&type=chunk)[153](index=153&type=chunk) [Liquidity and Capital Resources](index=42&type=section&id=Liquidity%20and%20Capital%20Resources) The company faces critical liquidity with $1.1 million cash and a $5.2 million working capital deficit, raising going concern doubts, partially addressed by a $5.1 million warrant inducement - The company's **$1.1 million** cash balance and projected operating needs raise **substantial doubt** about its ability to continue as a **going concern** for the next year[155](index=155&type=chunk) - The working capital deficit increased to **($5.2 million)** at March 31, 2025, from a **$1.8 million** surplus at December 31, 2024, primarily due to reclassification of the senior secured credit facility[160](index=160&type=chunk) - Subsequent to the quarter, the company received **$5.1 million** in net proceeds from a warrant inducement, using **$1.0 million** to repay senior secured credit facility debt[159](index=159&type=chunk)[166](index=166&type=chunk) [Item 3. Quantitative and Qualitative Disclosures about Market Risk](index=48&type=section&id=Item%203.%20Quantitative%20and%20Qualitative%20Disclosures%20about%20Market%20Risk) No material changes have occurred in the company's quantitative and qualitative market risk disclosures since its 2024 Annual Report on Form 10-K - There have been **no material changes** to the market risk disclosures from the company's most recent Annual Report on Form 10-K[177](index=177&type=chunk) [Item 4. Controls and Procedures](index=48&type=section&id=Item%204.%20Controls%20and%20Procedures) Management concluded that disclosure controls and procedures were effective as of March 31, 2025, with no material changes to internal control over financial reporting during the quarter - The CEO and CFO concluded that the company's disclosure controls and procedures were **effective** as of the end of the first quarter of 2025[179](index=179&type=chunk) - **No material changes** were made to the company's internal control over financial reporting during the quarter ended March 31, 2025[180](index=180&type=chunk) [Part II. Other Information](index=39&type=section&id=PART%20II.%20OTHER%20INFORMATION) [Item 1. Legal Proceedings](index=49&type=section&id=Item%201.%20Legal%20Proceedings) The company is involved in various legal proceedings, including a shareholder derivative case, insurance litigation, and contract disputes, as detailed in Note 12 - The company is subject to **various legal proceedings**, including a shareholder derivative case, an insurance claim dispute, and contract disputes, as detailed in Note 12[182](index=182&type=chunk) [Item 1A. Risk Factors](index=49&type=section&id=Item%201A.%20Risk%20Factors) No material changes have occurred in the company's risk factors since its 2024 Annual Report on Form 10-K filing - **No material changes** have occurred in the company's risk factors since the filing of its 2024 Annual Report on Form 10-K[183](index=183&type=chunk) [Item 2. Unregistered Sales of Equity Securities and Use of Proceeds](index=49&type=section&id=Item%202.%20Unregistered%20Sales%20of%20Equity%20Securities%20and%20Use%20of%20Proceeds) The company reported no unregistered sales of equity securities during the period - No unregistered sales of equity securities occurred during the period[184](index=184&type=chunk) [Item 5. Other Information](index=49&type=section&id=Item%205.%20Other%20Information) No modifications were made to director or officer trading plans under Rule 10b5-1(c) during the first quarter of 2025 - **No modifications** were made to director or officer trading plans under Rule 10b5-1(c) during the quarter[184](index=184&type=chunk) [Item 6. Exhibits](index=50&type=section&id=Item%206.%20Exhibits) This section lists exhibits filed with the Form 10-Q, including CEO and CFO certifications and Inline XBRL data files - Filed exhibits include **Section 302 and 906 certifications** by the CEO and CFO, along with **XBRL data files**[187](index=187&type=chunk)